New Zealand markets open in 2 hours 23 minutes

Catalyst Pharmaceuticals, Inc. (CPRX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
16.60+0.11 (+0.67%)
As of 03:37PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 1.95B
Enterprise value 1.64B
Trailing P/E 29.45
Forward P/E 11.82
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.65
Price/book (mrq)3.47
Enterprise value/revenue 3.99
Enterprise value/EBITDA 14.39

Trading information

Stock price history

Beta (5Y monthly) 0.89
52-week change 331.60%
S&P500 52-week change 326.16%
52-week high 317.50
52-week low 311.09
50-day moving average 315.66
200-day moving average 314.32

Share statistics

Avg vol (3-month) 31.34M
Avg vol (10-day) 31.19M
Shares outstanding 5118.11M
Implied shares outstanding 6118.01M
Float 8101.89M
% held by insiders 16.21%
% held by institutions 177.46%
Shares short (30 Apr 2024) 47.71M
Short ratio (30 Apr 2024) 45.99
Short % of float (30 Apr 2024) 48.12%
Short % of shares outstanding (30 Apr 2024) 46.53%
Shares short (prior month 28 Mar 2024) 46.05M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 15.83%
Operating margin (ttm)27.54%

Management effectiveness

Return on assets (ttm)9.29%
Return on equity (ttm)14.55%

Income statement

Revenue (ttm)411.35M
Revenue per share (ttm)3.77
Quarterly revenue growth (yoy)15.40%
Gross profit (ttm)N/A
EBITDA 114.04M
Net income avi to common (ttm)65.12M
Diluted EPS (ttm)0.56
Quarterly earnings growth (yoy)-21.30%

Balance sheet

Total cash (mrq)310.41M
Total cash per share (mrq)2.63
Total debt (mrq)3.47M
Total debt/equity (mrq)0.62%
Current ratio (mrq)5.09
Book value per share (mrq)4.76

Cash flow statement

Operating cash flow (ttm)163.46M
Levered free cash flow (ttm)-34.3M